国盛证券指出，公司24Q3税后利润同比下降，主要由于研发费用及管理费用增长，其中研发费用主要用于加热不燃烧产品及雾化医疗产品。除自研项目外，公司与客户共同研发合作，未来有望为客户提供产品解决方案与相关技术服务，后续加热不燃烧产品及医疗雾化产品的研发投入有望逐步转化为公司新的收入及盈利增长点。SMORE International (06969) fell by more than 5%. As of press release, it was down 5.42% to HK$11.86, with a turnover of HK$0.304 billion.
The Zhitong Finance App learned that Smore International (06969) fell by more than 5%. As of press release, it fell 5.42% to HK$11.86, with a turnover of HK$0.304 billion.
According to the news, Smore International announced that it achieved revenue of 3.286 billion yuan in the third quarter of 2024, up 16.5% from the previous month, up 14.1% year on year; profit after tax was about 0.379 billion yuan, up 10.2% month on month and 22.5% year on year. According to the announcement, the company's profit after tax fell by about 22.5% year-on-year during the period, mainly due to a significant increase in estimated income tax expenses during the period compared to the same period last year.
Guosheng Securities pointed out that the company's 24Q3 profit declined year-on-year, mainly due to increased R&D expenses and management expenses. Among them, R&D expenses were mainly used for heating non-combustible products and atomized medical products. In addition to self-research projects, the company cooperates with customers in joint R&D and is expected to provide customers with product solutions and related technical services in the future. Subsequent R&D investment in heated non-combustible products and medical atomization products is expected to gradually transform into a new revenue and profit growth point for the company.
